From GlobeNewswire: 2024-04-12 02:00:00

RIBER, a global leader in molecular beam epitaxy equipment, reported strong 2023 full-year earnings. Revenues reached €39.3m (+41%), with MBE systems driving a 96% increase. Operating income was €3.9m, representing 10% of revenues. Net income was €3.4m (8.7% of revenues). The company aims for continued growth in 2024, proposing a €0.07 per share payout for 2023 earnings and simplifying governance structure.

Despite a volatile geopolitical environment, RIBER met its revenue target in 2023, attributing growth to strong MBE system sales. The release of the MBE 8000 system enhances mass production capabilities, offering new opportunities. Full-year revenues rose to €39.3m (+41%), driven by a 96% increase in MBE system sales, while services and accessories sales declined by 21%.

Financially, RIBER saw notable improvements in 2023. The gross margin increased to €13.2m, with operating income at €3.9m (10% of revenues). Net income rose to €3.4m, significantly higher than the previous year. Cash position was positive at €9.7m, with shareholders’ equity at €21.2m.

The order book at year-end 2023 was €26.3m, with notable new order intake starting 2024. Future outlook points to further revenue and earnings growth. A proposed cash payout of €0.07 per share demonstrates confidence in the company’s performance. Governance restructuring aims to simplify decision-making and support expansion.

RIBER’s cutting-edge equipment serves the semiconductor industry, accelerating electronics performance. The company’s innovation and market leadership drive advancements in various applications. Investors can anticipate the release of the full-year financial report after audit procedures are finalized. Next key dates include the 2024 first-quarter revenues release and the General Meeting on June 19, 2024.



Read more at GlobeNewswire:: Strong growth in 2023 full-year earnings